AID systems were associated with varying glycemic outcomes in type 1 diabetes, with MiniMed 780G users demonstrating best time in range.

The FDA has expanded its indication for Medtronic’s Guardian Sensor 3, allowing patients to wear the sensor on their upper arm. The sensor is part of Medtronic’s MiniMed 670G system, and is currently ...

The FDA issued a warning to patients who use a particular insulin pump system that unauthorized people could access it and change how much insulin a patient receives. In the warning posted Sept. 20, ...

Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement on Wednesday.

Medtronic plc.'s MDT Diabetes Management segment is dominating the headlines of late. Following the company’s receipt of the CE Mark approval for its advanced continuous glucose monitoring (CGM) ...

Medtronic is warning of a potential safety risk involving its MiniMed insulin pumps that has led to at least one hospitalization and one death, according to the Star Tribune. Medtronic said its ...

The FDA approved Medtronic's latest MiniMed insulin pump system, the company announced late last week. Indicated for individuals with type 1 diabetes ages 7 and older, the MiniMed 780G system pairs ...

The US Food and Drug Administration has approved Medtronic Minimed's 780G automated insulin delivery system with the Guardian 4 sensor. The latest so-called artificial pancreas system is approved for ...

Medtronic has secured a new approval in Europe, greatly expanding the reach of its MiniMed 780G pump system—including for people with Type 2 diabetes who require insulin. The CE mark also opens it up ...